
A 438079
CAS No. 899507-36-9
A 438079( —— )
Catalog No. M26041 CAS No. 899507-36-9
A 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 37 | In Stock |
![]() ![]() |
5MG | 59 | In Stock |
![]() ![]() |
10MG | 88 | In Stock |
![]() ![]() |
25MG | 170 | In Stock |
![]() ![]() |
50MG | 282 | In Stock |
![]() ![]() |
100MG | 500 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameA 438079
-
NoteResearch use only, not for human use.
-
Brief DescriptionA 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9).
-
DescriptionA 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9).(In Vitro):A 438079 blocks BzATP-(10 μM) evoked changes in intracellular calcium concentrations with an IC50 of 321 nM in 1321N1 cells stably expressing rat P2X7 receptors. A 438079 is also selective for the P2X7 receptor, at concentrations up to 100 μM.(In Vivo):In neuropathic rats noxious and innocuous evoked activity of different classes of spinal neurons is reduced by A 438079 (80 μmol/kg, i.v.), and it significantly raises withdrawal thresh-olds in both the SNL and CCI models. A 438079 has superior neuroprotective effects compared with an equal dose of phenobarbital (25 mg/kg). A 438079 partially but significantly prevents the 6-OHDA-induced depletion of striatal DA stores. Pretreatment with A 438079 reduces nociceptive behavior scores in the HC model.
-
In VitroIn 1321N1 cells stably expressing rat P2X7?receptors, A 438079 blocks BzATP-(10 μM) evoked changes in intracellular calcium concentrations with an IC50 of 321 nM. A 438079 is also selective for the P2X7 receptor, at concentrations up to 100 μM.
-
In VivoA 438079 (80 μmol/kg, i.v.) reduces noxious and innocuous evoked activity of different classes of spinal neurons in neuropathic rats. A 438079 (100 and 300 μmol/kg, i.p.) significantly raises withdrawal thresh-olds in both the SNL and CCI models. Intraperitoneal injection of A 438079 (5 and 15 mg/kg) 60 min after triggering seizures reduces seizure severity and neuronal death within the hippocampus. A 438079 has superior neuroprotective effects compared with an equally dose of phenobarbital (25 mg/kg).?A 438079 partially but significantly prevents the 6-OHDA-induced depletion of striatal DA stores. Pretreatment with A 438079 reduces nociceptive behaviour scores in the HC model.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorTRPM4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number899507-36-9
-
Formula Weight306.15
-
Molecular FormulaC13H9Cl2N5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (326.64 mM)
-
SMILESClc1cccc(-c2nnnn2Cc2cccnc2)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.9-Phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels[J]. British Journal of Pharmacology, 2010, 153(8):1697-1705.
molnova catalog



related products
-
CE-224535
CE-224535 is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.
-
Brilliant blue G-250
Brilliant Blue G is an antagonist of the P2X7 purinergic receptor.
-
A 438079
A 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9).